AFP and hepatocellular carcinoma: The modification of a constitutive promoter in pEPI with tumor-specific promoters can generate a vector that episomally expresses the transgene in tumor cells.100 For example, pEPito derivatives have been compared with constitutive CMV or EF-1α promoters and with alpha fetoprotein (AFP) promoter in liver carcinoma.